Treprostinil Ultrasonic Nebulizer

DEVICE4 trials

Sponsors

United Therapeutics

Conditions

Idiopathic Pulmonary FibrosisInterstitial Lung DiseaseProgressive Pulmonary Fibrosis

Phase 3

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

CompletedNCT04708782

United TherapeuticsIdiopathic Pulmonary Fibrosis, Interstitial Lung Disease

Start: 2021-06-01End: 2026-02-02Updated: 2026-02-10

Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

Enrolling by invitationNCT04905693

United TherapeuticsIdiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis

Start: 2022-09-06End: 2026-06-01Target: 1850Updated: 2026-03-31

Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

CompletedNCT05255991

United TherapeuticsIdiopathic Pulmonary Fibrosis, Interstitial Lung Disease

Start: 2022-10-04End: 2025-06-30Updated: 2025-08-15

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

RecruitingNCT05943535

United TherapeuticsInterstitial Lung Disease, Progressive Pulmonary Fibrosis

Start: 2023-10-30End: 2027-11-01Target: 698Updated: 2026-03-31

Related Papers

Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.

2026-03-11

TETON-PPF Clinical Trial of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis: Preliminary Baseline Demographics

American Journal of Respiratory and Critical Care Medicine2025-05-011 citations

Teton Phase 3 Clinical Trials of Inhaled Treprostinil in the Treatment of Idiopathic Pulmonary Fibrosis: Annual Update of Preliminary Baseline Data

American Journal of Respiratory and Critical Care Medicine2025-05-01

A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema.

2024-01-182 citations

Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis

BMJ Open Respiratory Research2022-07-0157 citations